NCT05763017

Brief Summary

The purpose of this study is to compare the effectiveness of relative motion splint and metacarpophalangeal joint blocking splints in terms of sign and symptoms, hand function, occupational performance, and perception of splint wearability (comfort and satisfaction) after six weeks of TF management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 28, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 10, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 24, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 24, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.8 years

First QC Date

February 28, 2023

Last Update Submit

September 10, 2024

Conditions

Keywords

relative motion splintmetacarpophalangeal joint blocking splint

Outcome Measures

Primary Outcomes (1)

  • Stages of Stenosing Tenosynovitis (SST)

    SST is a grading system that divides trigger finger into six stages. Stage 1 is normal; Stage 2 is uneven finger movement; Stage 3 is triggering or clicking or catching; Stage 4 is locking of finger in flexion or extension, which can be unlocked by active finger movement; Stage 5 is locking of finger in flexion or extension, which requires application of passive force to unlock; and Stage 6 is locked finger in flexion or extension

    Baseline, 6 weeks after splint wear

Secondary Outcomes (6)

  • Visual Analog Scale (VAS) for pain

    Baseline, 6 weeks after splint wear

  • Number of triggering events in ten active fists

    Baseline, 6 weeks after splint wear

  • Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure

    Baseline, 6 weeks after splint wear

  • Canadian Occupational Performance Measure (COPM)

    Baseline, 6 weeks after splint wear

  • Visual Analog Scale (VAS) for splint comfort

    Baseline, 3 and 6 weeks after splint wear

  • +1 more secondary outcomes

Study Arms (2)

Relative Motion Splint

EXPERIMENTAL

In the relative motion splint, the metacarpophalangeal joint of the affected finger(s) positioned in approximately 20°-25° more extension/flexion than metacarpophalangeal joint of the adjacent fingers.

Other: Relative Motion Splint

Metacarpophalangeal Joint Blocking Splint

ACTIVE COMPARATOR

In the metacarpophalangeal joint blocking splint, the metacarpophalangeal joint of the affected finger(s) positioned in 0°.

Other: Metacarpophalangeal Joint Blocking Splint

Interventions

Six weeks relative motion splint wear.

Relative Motion Splint

Six weeks metacarpophalangeal joint blocking splint wear.

Metacarpophalangeal Joint Blocking Splint

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • single or multiple trigger finger
  • unilateral or bilateral trigger finger
  • neutral metacarpophalangeal joint position can be attained during passive isolated metacarpophalangeal joint extension of the affected finger

You may not qualify if:

  • trigger thumb
  • steroid injection of the affected finger within last six months
  • A1 pulley release of the affected finger.
  • history of fracture, tendon injury, nerve injury, Dupuytren's contracture, and other soft tissue injuries of the affected finger or adjacent fingers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sultan Haji Ahmad Shah

Temerluh, Pahang, 28000, Malaysia

Location

Related Publications (2)

  • Leong LX, Chai SC, Howell JW, Rasdi HFM, Rahman NRA. A randomized comparative trial: Relative motion vs metacarpophalangeal joint blocking orthoses for trigger finger management. J Hand Ther. 2025 Jul 4:S0894-1130(25)00090-0. doi: 10.1016/j.jht.2025.05.018. Online ahead of print.

  • Leong LX, Chai SC, Howell JW, Mohd Rasdi HF, Abdul Rahman NR. Relative motion splints versus metacarpophalangeal joint blocking splints in the management of trigger finger: Study protocol for a randomized comparative trial. PLoS One. 2024 Aug 13;19(8):e0307033. doi: 10.1371/journal.pone.0307033. eCollection 2024.

MeSH Terms

Conditions

Trigger Finger DisorderTendon Entrapment

Condition Hierarchy (Ancestors)

TendinopathyMuscular DiseasesMusculoskeletal Diseases

Study Officials

  • Siaw Chui Chai, PhD (OT)

    Occupational Therapy Programme, Center for Rehabilitation & Special Needs Studies (iCaRehab)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2023

First Posted

March 10, 2023

Study Start

June 28, 2022

Primary Completion

April 24, 2024

Study Completion

April 24, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations